Comparison Caris Life Sciences (CAI) with Competitors
Caris Life Sciences (CAI) industry is Biotechnology.
Profit Margin
CAI27.98%
Industry-0.77%
Upside+28.75%
Operating Margin
CAI30.19%
Industry-2055.25%
Upside+2085.44%
Debt-to-Equity
CAI64.29%
Industry28.27%
Upside+127.44%
Free Cash Flow Yield
CAI2.50%
Industry-1.75%
Upside+4.25%
P/E
CAI-72.45
Industry-20.52
Upside-5193.17%
Forward P/E
CAI43.29
Industry16.33
Upside+165.09%
P/S
CAI5.44
Industry10.01
Upside-45.67%
P/B
CAI8.07
Industry5.15
Upside+56.80%